Because the quality of cost-effectiveness studies related to the Thai context is still limited, the Thai health technology assessment guidelines have been firstly developed in Thailand for researchers to stimulate the provision of standardized, reliable and good quality information which can be used by policy makers and healthcare personnel for mak

Veronika J Wirtz*, Hans V Hogerzeil*, Andrew L Gray*, Maryam Bigdeli, Cornelis P de Joncheere, Margaret A Ewen, Martha Gyansa-Lutterodt, Sun Jing, Vera L Luiza, Regina M Mbindyo, Helene Möller, Corrina Moucheraud, Bernard Pécoul, Lembit Rägo, Arash Rashidian, Dennis Ross-Degnan, Peter N Stephens,

Abstract A trend towards charging for access to research findings, tools and databases is becoming more prominent globally. But charging for the use of research tools and databases that are vital to research supporting national and international policy development might be unjustified. Financial

On 17th September 2018, Sarah Garner, coordinator of the Innovation, Access and Use team under the Essential Medicines and Health Products program, World Health Organization, had an informal meeting at the Health Intervention and Technology Assessment Program (HITAP). She was eager to learn about HI

Digital health interventions (DHIs), such as electronic decision support tools, telemonitoring, or mobile health (mHealth) apps, have the potential to address health system challenges that limit the achievement of universal health coverage (UHC). Regional economic development and a growing ageing

Last month, I had the opportunity to attend the PMAC 2018 conference. I cannot help myself expressing immense pleasure to be a part as a participant in the mega event where I met many intelligent and sharp international colleagues and one health expert from different one health global netwo

Acknowledgements This report was prepared by Dr. Shiela Marie Selisana and Ms. Thitipanchaya Panya from the Health Intervention and Technology Assessment Program Foundation (HITAP) and reviewed by Ms. Saudamini Vishwanath Dabak. The authors are grateful to Dr. Zin Nwe Win for her invaluable as

Dr. Nishanta Sharma is a quantitative researcher at HITAP Thailand, currently leading a project that assesses the environmental and economic impacts of low-value healthcare services using input-output analysis, as well as exploring the nexus between climate and epidemiology. He holds a PhD in Development and Sustainability from the Asian Institute

Diseases are caused by a range of risk factors, some of which are modifiable risk factors. Understanding the health cost burden associated with each modifiable risk factor can provide valuable insights for the health system, such as helping prioritize public health interventions that target the most harmful risk factors or designing programs that c

The Government of the Democratic People’s Republic of Korea (DPR Korea) was one of the first countries to successfully apply for Gavi, the Vaccine Alliance’s (Gavi) new funding window on health systems strengthening (HSS) in 2006 and was subsequently awarded a second Gavi HSS grant in 2014. The Heal